Coming in the Air: Hypoxia Meets Epigenetics in Pancreatic Cancer

With a five-year survival rate under 9%, pancreatic ductal adenocarcinoma (PDAC) represents one of the deadliest tumors. Although the treatment options are slightly improving, PDAC is the second leading cause of cancer related death in 2020 in the US. In addition to a pronounced desmoplastic stroma...

Full description

Bibliographic Details
Main Authors: Claudia Geismann, Alexander Arlt
Format: Article
Language:English
Published: MDPI AG 2020-10-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/9/11/2353
_version_ 1797549900209061888
author Claudia Geismann
Alexander Arlt
author_facet Claudia Geismann
Alexander Arlt
author_sort Claudia Geismann
collection DOAJ
description With a five-year survival rate under 9%, pancreatic ductal adenocarcinoma (PDAC) represents one of the deadliest tumors. Although the treatment options are slightly improving, PDAC is the second leading cause of cancer related death in 2020 in the US. In addition to a pronounced desmoplastic stroma reaction, pancreatic cancer is characterized by one of the lowest levels of oxygen availability within the tumor mass and these hypoxic conditions are known to contribute to tumor development and progression. In this context, the major hypoxia associated transcription factor family, HIF, regulates hundreds of genes involved in angiogenesis, metabolism, migration, invasion, immune escape and therapy resistance. Current research implications show, that hypoxia also modulates diverse areas of epigenetic mechanisms like non-coding RNAs, histone modifications or DNA methylation, which cooperate with the hypoxia-induced transcription factors as well as directly regulate the hypoxic response pathways. In this review, we will focus on hypoxia-mediated epigenetic alterations and their impact on pancreatic cancer.
first_indexed 2024-03-10T15:20:57Z
format Article
id doaj.art-a9be00762cdf43f69fe3120c47775756
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-10T15:20:57Z
publishDate 2020-10-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-a9be00762cdf43f69fe3120c477757562023-11-20T18:28:24ZengMDPI AGCells2073-44092020-10-01911235310.3390/cells9112353Coming in the Air: Hypoxia Meets Epigenetics in Pancreatic CancerClaudia Geismann0Alexander Arlt1Laboratory of Molecular Gastroenterology & Hepatology, Department of Internal Medicine I, UKSH-Campus Kiel, 24105 Kiel, GermanyLaboratory of Molecular Gastroenterology & Hepatology, Department of Internal Medicine I, UKSH-Campus Kiel, 24105 Kiel, GermanyWith a five-year survival rate under 9%, pancreatic ductal adenocarcinoma (PDAC) represents one of the deadliest tumors. Although the treatment options are slightly improving, PDAC is the second leading cause of cancer related death in 2020 in the US. In addition to a pronounced desmoplastic stroma reaction, pancreatic cancer is characterized by one of the lowest levels of oxygen availability within the tumor mass and these hypoxic conditions are known to contribute to tumor development and progression. In this context, the major hypoxia associated transcription factor family, HIF, regulates hundreds of genes involved in angiogenesis, metabolism, migration, invasion, immune escape and therapy resistance. Current research implications show, that hypoxia also modulates diverse areas of epigenetic mechanisms like non-coding RNAs, histone modifications or DNA methylation, which cooperate with the hypoxia-induced transcription factors as well as directly regulate the hypoxic response pathways. In this review, we will focus on hypoxia-mediated epigenetic alterations and their impact on pancreatic cancer.https://www.mdpi.com/2073-4409/9/11/2353pancreatic cancerhypoxiaHIFepigeneticsDNA methylationnon-coding RNA
spellingShingle Claudia Geismann
Alexander Arlt
Coming in the Air: Hypoxia Meets Epigenetics in Pancreatic Cancer
Cells
pancreatic cancer
hypoxia
HIF
epigenetics
DNA methylation
non-coding RNA
title Coming in the Air: Hypoxia Meets Epigenetics in Pancreatic Cancer
title_full Coming in the Air: Hypoxia Meets Epigenetics in Pancreatic Cancer
title_fullStr Coming in the Air: Hypoxia Meets Epigenetics in Pancreatic Cancer
title_full_unstemmed Coming in the Air: Hypoxia Meets Epigenetics in Pancreatic Cancer
title_short Coming in the Air: Hypoxia Meets Epigenetics in Pancreatic Cancer
title_sort coming in the air hypoxia meets epigenetics in pancreatic cancer
topic pancreatic cancer
hypoxia
HIF
epigenetics
DNA methylation
non-coding RNA
url https://www.mdpi.com/2073-4409/9/11/2353
work_keys_str_mv AT claudiageismann comingintheairhypoxiameetsepigeneticsinpancreaticcancer
AT alexanderarlt comingintheairhypoxiameetsepigeneticsinpancreaticcancer